Akèy › Maladi ren kwonik › Arizona › Phoenix
Etid klinik pou Maladi ren kwonik nan Phoenix, AZ
5 etid pou Maladi ren kwonik ap chèche patisipan nan sit nan ak bò kote Phoenix (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Ap rekriteFaz 3
- Research Site, Phoenix
Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus
Ap rekrite
- Arizona Kidney Disease and Hypertension Center, Phoenix
American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)
Ap rekriteEtid obsèvasyon
- NIDDK-Phoenix Epidemiology and Clinical Research, Phoenix
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
Ap rekrite
- Arizona Kidney Disease & Hypertension Centers (AKDHC) Phoenix Surgery Center, Phoenix
A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
Ap rekrite
- AKDHC Medical Research Services, LLC, Phoenix
Etid Maladi ren kwonik nan lòt vil
- New York City, NY16 etid
- Houston, TX15 etid
- Boston, MA15 etid
- Dallas, TX15 etid
- Philadelphia, PA15 etid
- Chicago, IL12 etid
- Orlando, FL11 etid
- Atlanta, GA10 etid
- Kansas City, MO9 etid
- Durham, NC9 etid
- Washington, DC8 etid
- Albuquerque, NM8 etid
Lòt etid nan Phoenix
- Kansè nan tete25 etid
- Kansè kolorektal25 etid
- Obèsite22 etid
- Kansè Poumon ki pa ti selil20 etid
- Kansè Metastatik20 etid
- Ensifizyans kadyak18 etid
- Kansè pwostat17 etid
- Kansè (tout kalite)17 etid
- Myelom Miltip16 etid
- Kansè pankreyas16 etid
- Maladi kadyovaskilè16 etid
- Maladi Alzheimer15 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.